Kip KE - Search Results

1

Infliximab prevents Crohn's disease recurrence after ileal resection.

Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE. Regueiro M, et al. Among authors: kip ke. Gastroenterology. 2009 Feb;136(2):441-50.e1; quiz 716. doi: 10.1053/j.gastro.2008.10.051. Epub 2008 Oct 31. Gastroenterology. 2009. PMID: 19109962 Clinical Trial.

2

Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease.

Regueiro M, El-Hachem S, Kip KE, Schraut W, Baidoo L, Watson A, Swoger J, Schwartz M, Barrie A, Pesci M, Binion D. Regueiro M, et al. Among authors: kip ke. Dig Dis Sci. 2011 Dec;56(12):3610-5. doi: 10.1007/s10620-011-1785-9. Epub 2011 Jun 17. Dig Dis Sci. 2011. PMID: 21681507 Clinical Trial.

3

Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.

Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W. Regueiro M, et al. Among authors: kip ke. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1494-502.e1. doi: 10.1016/j.cgh.2013.12.035. Epub 2014 Jan 16. Clin Gastroenterol Hepatol. 2014. PMID: 24440221 Clinical Trial.

4

Infliximab dose intensification in Crohn's disease.

Regueiro M, Siemanowski B, Kip KE, Plevy S. Regueiro M, et al. Among authors: kip ke. Inflamm Bowel Dis. 2007 Sep;13(9):1093-9. doi: 10.1002/ibd.20177. Inflamm Bowel Dis. 2007. PMID: 17480021

5

Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center.

Lazarev M, Ullman T, Schraut WH, Kip KE, Saul M, Regueiro M. Lazarev M, et al. Among authors: kip ke. Inflamm Bowel Dis. 2010 May;16(5):830-5. doi: 10.1002/ibd.21118. Inflamm Bowel Dis. 2010. PMID: 19798731 Clinical Trial.

6

Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection.

Regueiro M, Kip KE, Schraut W, Baidoo L, Sepulveda AR, Pesci M, El-Hachem S, Harrison J, Binion D. Regueiro M, et al. Among authors: kip ke. Inflamm Bowel Dis. 2011 Jan;17(1):118-26. doi: 10.1002/ibd.21355. Inflamm Bowel Dis. 2011. PMID: 20848538 Clinical Trial.

7

Reply: To PMID 24530602.

Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W. Regueiro M, et al. Among authors: kip ke. Clin Gastroenterol Hepatol. 2014 Aug;12(8):1407. doi: 10.1016/j.cgh.2014.03.002. Epub 2014 Mar 12. Clin Gastroenterol Hepatol. 2014. PMID: 24614332 No abstract available.

8

Reply: To PMID 24440221.

Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W. Regueiro M, et al. Among authors: kip ke. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1764-5. doi: 10.1016/j.cgh.2014.06.015. Epub 2014 Jun 20. Clin Gastroenterol Hepatol. 2014. PMID: 24956081 No abstract available.

9

Cigarette smoking and age at diagnosis of inflammatory bowel disease.

Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S. Regueiro M, et al. Among authors: kip ke. Inflamm Bowel Dis. 2005 Jan;11(1):42-7. doi: 10.1097/00054725-200501000-00006. Inflamm Bowel Dis. 2005. PMID: 15674112

10

Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity.

Regueiro M, Rodemann J, Kip KE, Saul M, Swoger J, Baidoo L, Schwartz M, Barrie A, Binion D. Regueiro M, et al. Among authors: kip ke. Inflamm Bowel Dis. 2011 Apr;17(4):1008-14. doi: 10.1002/ibd.21445. Epub 2010 Sep 1. Inflamm Bowel Dis. 2011. PMID: 20812333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters